Senior Applied AI/ML Engineer
TetraScience- Full Time
- Senior (5 to 8 years)
Salary: $152K - $215K Location Type: Remote Employment Type: Full-Time
Iambic Therapeutics is seeking a Machine Learning Scientist II or Senior to enhance our Enchant platform with clinically relevant imaging. The successful candidate will design and build models that learn from medical images and integrate them with multimodal biomedical data to advance drug discovery and clinical decision-making.
Iambic is a clinical-stage life-science and technology company dedicated to developing novel medicines through its AI-driven discovery and development platform. Founded in 2020 and based in San Diego, Iambic has assembled a world-class team of pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated the ability to deliver new drug candidates to human clinical trials with unprecedented speed across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and through partnerships, to address urgent unmet patient needs.
Learn more about the Iambic team, platform, pipeline, and partnerships at iambic.ai.
Our mission is to deliver better medicines through innovations in AI-based discovery technologies. The culture and work at Iambic Therapeutics are profoundly strengthened by the diversity of our people and our differences in background, culture, national origin, religion, sexual orientation, and life experiences. We are committed to building an inclusive environment where a diverse group of talented humans work together to discover therapeutics and create technologies.
We offer industry-leading competitive pay, company-paid healthcare, flexible spending accounts, voluntary life insurance, 401K matching, and uncapped vacation. Our team enjoys a brand-new, state-of-the-art facility in beautiful San Diego, featuring an on-site gym, dining, and easy access to great living and recreational areas.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.